APA (7th ed.) Citation

Fan, W., Zhu, B., Zheng, X., Yue, S., Lu, M., Fan, H., . . . Li, J. (2023). Sorafenib plus drug-eluting bead transarterial chemoembolization for early intrahepatic stage-progressed advanced hepatocellular carcinoma refractory to conventional transarterial chemoembolization. Journal of cancer research and clinical oncology, 149(5), 1873-1882. https://doi.org/10.1007/s00432-022-04107-w

Chicago Style (17th ed.) Citation

Fan, Wenzhe, et al. "Sorafenib Plus Drug-eluting Bead Transarterial Chemoembolization for Early Intrahepatic Stage-progressed Advanced Hepatocellular Carcinoma Refractory to Conventional Transarterial Chemoembolization." Journal of Cancer Research and Clinical Oncology 149, no. 5 (2023): 1873-1882. https://doi.org/10.1007/s00432-022-04107-w.

MLA (9th ed.) Citation

Fan, Wenzhe, et al. "Sorafenib Plus Drug-eluting Bead Transarterial Chemoembolization for Early Intrahepatic Stage-progressed Advanced Hepatocellular Carcinoma Refractory to Conventional Transarterial Chemoembolization." Journal of Cancer Research and Clinical Oncology, vol. 149, no. 5, 2023, pp. 1873-1882, https://doi.org/10.1007/s00432-022-04107-w.